| 000 | 01932cam a22005058i 4500 | ||
|---|---|---|---|
| 001 | 9781315222929 | ||
| 003 | FlBoTFG | ||
| 005 | 20220711212832.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 170321s2017 onc ob 001 0 eng | ||
| 040 |
_aOCoLC-P _beng _erda _cOCoLC-P |
||
| 020 |
_a9781315222929 _q(electronic bk.) |
||
| 020 |
_a1315222922 _q(electronic bk.) |
||
| 020 |
_a9781315225371 _q(electronic bk.) |
||
| 020 |
_a1315225379 _q(electronic bk.) |
||
| 020 | _z9781315225364 | ||
| 020 | _z1315225360 | ||
| 020 |
_z9781771885836 _q(hardcover ; _qv. 1 ; _qalk. paper) |
||
| 035 | _a(OCoLC)978295602 | ||
| 035 | _a(OCoLC-P)978295602 | ||
| 050 | 1 | 0 | _aRS420 |
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 082 | 0 | 0 |
_a615.1/9 _223 |
| 245 | 0 | 0 |
_aDrug delivery approaches and nanosystems / _ceditors, Raj K. Keservani, Anil K. Sharma, Rajesh K. Kesharwani. |
| 264 | 1 |
_aToronto ; _aNew Jersey : _bApple Academic Press, _c2017. |
|
| 300 | _a1 online resource | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 505 | 0 | _aV.1. Novel drug carriers -- v. 2. Drug targeting aspects of nanotechnology. | |
| 588 | _aOCLC-licensed vendor bibliographic record. | ||
| 650 | 0 |
_aDrug delivery systems. _97290 |
|
| 650 | 0 |
_aNanotechnology. _94707 |
|
| 650 | 0 |
_aNanostructures. _95928 |
|
| 650 | 7 |
_aMEDICAL / Pharmacology _2bisacsh _97291 |
|
| 700 | 1 |
_aKeservani, Raj K., _d1981- _eeditor. _920055 |
|
| 700 | 1 |
_aSharma, Anil K., _d1980- _eeditor. _920056 |
|
| 700 | 1 |
_aKesharwani, Rajesh Kumar, _d1978- _eeditor. _920057 |
|
| 730 | 0 | 2 |
_aNovel drug carriers. _917651 |
| 730 | 0 | 2 |
_aDrug targeting aspects of nanotechnology. _917650 |
| 856 | 4 | 0 |
_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9781315222929 |
| 856 | 4 | 2 |
_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
| 942 | _cEBK | ||
| 999 |
_c72273 _d72273 |
||